Swiderska-Chadaj, Zaneta
de Bel, Thomas
Blanchet, Lionel
Baidoshvili, Alexi
Vossen, Dirk
van der Laak, Jeroen
Litjens, Geert
Funding for this research was provided by:
This research was funded by Philips Digital and Computational Pathology.
Article History
Received: 7 April 2020
Accepted: 12 August 2020
First Online: 1 September 2020
Competing interests
: Geert Litjens reports grants from the Dutch Cancer Society, and grants from Philips Digital Pathology Solutions during the conduct of the study; consultancy fees from Novartis, outside the submitted work. Jeroen van der Laak is a member of the scientific advisory boards of Philips, the Netherlands and ContextVision, Sweden, and receives research funding from Philips, the Netherlands, and Sectra, Sweden. Alexi Baidoshvili is a member of the scientific advisory boards of Philips. Dirk Vossen and Lionel Blanchet are directly employed by Philips Digital and Computational Pathology. Zaneta Swiderska-Chadaj and Thomas de Bel declare no conflict of interest.